Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-26T06:56:39.301Z Has data issue: false hasContentIssue false

Efficacy of the EG95 hydatid vaccine in a macropodid host, the tammar wallaby

Published online by Cambridge University Press:  06 February 2009

T. S. BARNES*
Affiliation:
The University of Queensland, School of Veterinary Science, 4072, Australia
L. A. HINDS
Affiliation:
CSIRO Entomology, G.P.O. Box 1700, Canberra, ACT 2602, Australia
D. J. JENKINS
Affiliation:
Parasitech, 55 Carstensz Street, Griffith, ACT 2603 Australian Hydatid Control and Research Laboratory, School of Animal and Veterinary Sciences, Charles Sturt University, Locked Bag 588, Wagga Wagga, NSW 2678, Australia
G. T. COLEMAN
Affiliation:
The University of Queensland, School of Veterinary Science, 4072, Australia
A. L. COLEBROOK
Affiliation:
The University of Melbourne, Veterinary Clinical Centre, 250 Princes Highway, Werribee, Victoria 3030, Australia
C. T. KYNGDON
Affiliation:
The University of Melbourne, Veterinary Clinical Centre, 250 Princes Highway, Werribee, Victoria 3030, Australia
C. G. GAUCI
Affiliation:
The University of Melbourne, Veterinary Clinical Centre, 250 Princes Highway, Werribee, Victoria 3030, Australia
M. W. LIGHTOWLERS
Affiliation:
The University of Melbourne, Veterinary Clinical Centre, 250 Princes Highway, Werribee, Victoria 3030, Australia
*
*Corresponding author: The University of Queensland, School of Veterinary Science, Queensland, 4072, Australia. Tel: +61 7 3365 3023. Fax: +61 7 3365 1255. E-mail: t.barnes@uq.edu.au

Summary

In Australia, macropodids are common intermediate hosts for the cestode Echinococcus granulosus, and sylvatic transmission is maintained via wild dogs. The parasite causes mortality in a number of macropodid species and the sylvatic cycle provides a source of infection to domestic livestock and humans. We determined the efficacy of the hydatid vaccine, EG95 in the tammar wallaby, Macropus eugenii, challenging either 1 or 9 months post-vaccination. EG95 provides similar protection to that seen in sheep (96–100%). Control tammars were significantly more likely to become infected (odds ratio 29·44; CI 4·13, 209·97; P=0·001) and to develop more cysts (count ratio 26·69; CI 5·83, 122·19; P<0·001). The vaccination may be beneficial if administered pre-release in captive breeding programmes for endangered macropodids. Further work to develop oral delivery methods may enable vaccine administration of wild animals and thereby a reduction in sylvatic transmission.

Type
Research Article
Copyright
Copyright © 2009 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Barnes, T. S., Hinds, L. A., Jenkins, D. J. and Coleman, G. T. (2007 a). Precocious development of hydatid cysts in a macropodid host. International Journal for Parasitology 37, 13791389.CrossRefGoogle Scholar
Barnes, T. S., Morton, J. M. and Coleman, G. T. (2007 b). Clustering of hydatid infection in macropodids. International Journal for Parasitology 37, 943952.CrossRefGoogle ScholarPubMed
Barnes, T. S., Goldizen, A. W., Morton, J. M. and Coleman, G. T. (2008). Cystic echinococcosis in a wild population of the brush-tailed rock-wallaby (Petrogale penicillata), a threatened macropodid. Parasitology 135, 715723.CrossRefGoogle Scholar
Blancou, J., Kieny, M. P., Lathe, R., Lecocq, J. P., Pastoret, P. P., Soulebot, J. P. and Desmettre, P. (1986). Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature, London 322, 373375.CrossRefGoogle ScholarPubMed
Bowles, J., Blair, D. and McManus, D. P. (1992). Genetic variants within the genus Echinococcus identified by mitochondrial DNA sequencing. Molecular and Biochemical Parasitology 54, 165173.CrossRefGoogle ScholarPubMed
Craig, P. S., McManus, D. P., Lightowlers, M. W., Chabalgoity, J. A., Garcia, H. H., Gavidia, C. M., Gilman, R. H., Gonzalez, A. E., Lorca, M., Naguira, C., Nieto, A. and Schantz, P. M. (2007). Prevention and control of cystic echinococcosis. Lancet Infectious Diseases 7, 385394.CrossRefGoogle ScholarPubMed
Cross, M. L., Buddle, B. M. and Aldwell, F. E. (2007). The potential of oral vaccines for disease control in wildlife species. Veterinary Journal 174, 472480.CrossRefGoogle ScholarPubMed
Eckert, J., Deplazes, P., Craig, P. S., Gemmell, M. A., Heath, D., Jenkins, D. J., Kamiya, M. and Lightowlers, M. (2001). Echinococcosis in animals: clinical aspects, diagnosis and treatment, In WHO/OIE Manual on Echinococcosis in Humans and Animals: a Public Health Problem of Global Concern (ed. Eckert, J., Gemmell, M. A., Meslin, F. X. and Pawlowski, Z.), pp. 7299. Office International des Epizooties, Paris, France.Google Scholar
Gemmell, M. A. (1966). Immunological responses of mammalian host against tapeworm infections IV. Species specificity of hexacanth embryos in protecting sheep against Echinococcus granulosus. Immunology 11, 325335.Google ScholarPubMed
Gemmell, M. A., Lawson, J. R. and Roberts, M. G. (1986). Population dynamics in echinococcosis and cysticercosis: Biological parameters of Echinococcus granulosus in dogs and sheep. Parasitology 92, 599620.CrossRefGoogle ScholarPubMed
Grainger, H. J. and Jenkins, D. J. (1996). Transmission of hydatid disease to sheep from wild dogs in Victoria, Australia. International Journal for Parasitology 26, 12631270.CrossRefGoogle ScholarPubMed
Haydon, D. T., Randall, D. A., Matthews, L., Knobel, D. L., Tallents, L. A., Gravenor, M. B., Williams, S. D., Pollinger, J. P., Cleaveland, S., Woolhouse, M. E. J., Sillero-Zubiri, C., Marino, J., Macdonald, D. W. and Laurenson, M. K. (2006). Low-coverage vaccination strategies for the conservation of endangered species. Nature, London 443, 692695.CrossRefGoogle ScholarPubMed
Heath, D. D., Jensen, O. and Lightowlers, M. W. (2003). Progress in control of hydatidosis using vaccination – a review of formulation and delivery of the vaccine and recommendations for practical use in control programmes. Acta Tropica 85, 133143.CrossRefGoogle ScholarPubMed
IUCN (2006). 2006 IUCN Red List of Threatened Species. Retrieved 5th February, 2007, from www.iucnredlist.orgGoogle Scholar
Jenkins, D. J. and Morris, B. (1991). Unusually heavy infections of Echinococcus granulosus in wild dogs in south-eastern Australia. Australian Veterinary Journal 68, 3637.CrossRefGoogle ScholarPubMed
Jenkins, D. J. and Macpherson, C. N. L. (2003). Transmission ecology of Echinococcus in wild-life in Australia and Africa. Parasitology 127, S63S72.CrossRefGoogle ScholarPubMed
Johnson, P. M., Speare, R. and Beveridge, I. (1998). Mortality in wild and captive rock-wallabies and nailtail wallabies due to hydatid disease caused by Echinococcus granulosus. Australian Mammalogy 20, 419423.CrossRefGoogle Scholar
Kilejian, A., Schinazi, L. A. and Schwabe, C. W. (1961). Host parasite relationships in echinococcosis 5. Histochemical observations on Echinococcus granulosus. Journal of Parasitology 47, 181188.CrossRefGoogle Scholar
Lahmar, S., Kilani, M. and Torgerson, P. R. (2001). Frequency distributions of Echinococcus granulosus and other helminths in stray dogs in Tunisia. Annals of Tropical Medicine and Parasitology 95, 6976.CrossRefGoogle ScholarPubMed
Lightowlers, M. W., Lawrence, S. B., Gauci, C. G., Young, J., Ralston, M. J., Maas, D. and Heath, D. D. (1996). Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunology 18, 457462.CrossRefGoogle ScholarPubMed
Lightowlers, M. W., Jensen, O., Fernandez, E., Iriarte, J. A., Woollard, D. J., Gauci, C. G., Jenkins, D. J. and Heath, D. D. (1999). Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. International Journal for Parasitology 29, 531534.CrossRefGoogle ScholarPubMed
Lightowlers, M. W. and Heath, D. D. (2004). Immunity and vaccine control of Echinococcus granulosus infection in animal intermediate hosts. Parassitologia 46, 2731.Google ScholarPubMed
Lightowlers, M. W. (2006). Cestode vaccines: origins, current status and future prospects. Parasitology 133, S27S42.CrossRefGoogle ScholarPubMed
Lillie, R. D. (1954). Histopathologic Technic and Practical Histochemistry. The Blakiston Company, Inc., New York, USA.Google Scholar
Lundie-Jenkins, G. and Lowry, J. (2005). Recovery plan for the bridled nailtail wallaby (Onychogalea fraenata) 2005–2009. Report to the Department of Environment and Heritage (DEH), Canberra. Environmental Protection Agency/Queensland Parks and Wildlife Service, Brisbane, AustraliaGoogle Scholar
McManus, D. P. and Thompson, R. C. A. (2003). Molecular epidemiology of cystic echinococcosis. Parasitology 127, S37S51.CrossRefGoogle ScholarPubMed
Menkhorst, P. and Jarman, P. (2005). National recovery plan for the brush-tailed rock wallaby Petrogale penicillata (Gray 1825). 2004/05–2008/09 (Melbourne, Victoria, Department of Sustainability and Environment).Google Scholar
Nolan, B. and Johnson, P. M. (2001). Recovery plan for the Proserpine rock-wallaby (Petrogale persephone) 2000–2004. Report to Environment Australia, Canberra. Queensland Parks and Wildlife Service, Brisbane, Australia.Google Scholar
Rupprecht, C. E., Hanlon, C. A. and Slate, D. (2004). Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control. In Control of Infectious Animal Diseases by Vaccination (ed. Schudel, A. and Lombard, M.),pp. 173184. Karger, Basel, Switzerland.Google Scholar
Thompson, R. C. A. and McManus, D. P. (2002). Towards a taxonomic revision of the genus Echinococcus. Trends in Parasitology 18, 452457.CrossRefGoogle ScholarPubMed
Woollard, D. J., Gauci, C. G., Heath, D. D. and Lightowlers, M. W. (1998). Epitope specificities and antibody responses to the EG95 hydatid vaccine. Parasite Immunology 20, 535540.CrossRefGoogle Scholar
Woollard, D. J., Gauci, C. G., Heath, D. D. and Lightowlers, M. W. (2000). Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes. Vaccine 19, 498507.CrossRefGoogle ScholarPubMed